Supplemental Appendix for Risk of immunogenicity during Infliximab therapy in Hidradenitis suppurativa compared with other Chronic Inflammatory Diseases: A Retrospective monocentric cohort : Supplemental Appendix
Published: 10 November 2025| Version 2 | DOI: 10.17632/w4z5sybj6d.2
Contributors:
, , Christina Bergqvist, Sophie Hue, Pierre Wolkenstein, Mathieu Uzzan, Pascal Claudepierre, , Description
Supplemental appendix fort brief report for "Risk of immunogenicity during Infliximab therapy in Hidradenitis suppurativa compared with other Chronic Inflammatory Diseases: A Retrospective monocentric cohort" published in Journal of the. American Academy of Dermatology
Files
Institutions
- Sorbonne Universite
Categories
Dermatology, Retrospective Study, Immunogenicity, Inflammatory Disorder, Hidradenitis Suppurativa